The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Award nominee oral presentations
Room:
A4
Facilitator:
Abstract:
10.30 – 11.50 | Award nominee oral presentations | A4 |
Section 1: Introductory Statements and Governance 10:30 Contamination of the blister packs by pomalidomide after use in clinical situation Iwaki, Takayuki Section 4: Clinical Pharmacy Services 10:40 Linezolid dosing in patients with liver cirrhosis: standard dosing risks’ toxicity Fernández-Sala, Xènia 10:50 Relationship between daily dose frequency and adherence in chronic myeloid leukaemia García Gil, Sara 11:00 Estimation of precision and accuracy of five population pharmacokinetics models of infliximab in patients with inflammatory bowel diseases Mas-Serrano, Patricio Section 5: Patient Safety and Quality Assurance 11:10 Computerised physician order entry impact on medication errors in a paediatric unit Gilabert Sotoca, Marta 11:20 Best practice of ward-based reconstitution in pediatric hospitals Nydert, Per Section 6: Education and Research 11:30 Becoming a hospital pharmacist: an observational cross-sectional study on the educational pathways from students’ perspective Mengato, Daniele 11:40 Design and implementation of a pharmacy technician training programme to improve outpatient drug dispensing Richard, Clementine |